Glucocorticoids promote intrinsic human TH17 differentiation - 06/11/18
Doi : 10.1016/j.jaci.2018.07.019
| Supported by the Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (Rückkehrerprogramm); the Center for Molecular Medicine, Cologne; the Köln Fortune Program, Cologne; and the Deutsche Forschungsgemeinschaft (SFB829, B13 and Z4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 5
P. 1669 - novembre 2018 Retour au numéro
Article précédent
- Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
- Lisa R. Forbes, Tiphanie P. Vogel, Megan A. Cooper, Johana Castro-Wagner, Edith Schussler, Katja G. Weinacht, Ashley S. Plant, Helen C. Su, Eric J. Allenspach, Mary Slatter, Mario Abinun, Desa Lilic, Charlotte Cunningham-Rundles, Olive Eckstein, Peter Olbrich, R. Paul Guillerman, Niraj C. Patel, Yesim Y. Demirdag, Christa Zerbe, Alexandra F. Freeman, Steven M. Holland, Paul Szabolcs, Andrew Gennery, Troy R. Torgerson, Joshua D. Milner, Jennifer W. Leiding
- Tertiary lymphoid organs: A novel target in patients with chronic rhinosinusitis
- Sathish Paramasivan, Susan Lester, Aden Lau, Judy Ou, Alkis James Psaltis, Peter-John Wormald, Sarah Vreugde
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?